Rosemary Hema Kufuor
About Rosemary Hema Kufuor
Rosemary Hema Kufuor is the Associate Director, PV Scientist, Hem/Onc at Bristol Myers Squibb, with extensive experience in safety science and clinical trials management.
Company
Rosemary Hema Kufuor currently holds the position of Associate Director, PV Scientist, Hem/Onc at Bristol Myers Squibb.
Title
Rosemary serves as an Associate Director, PV Scientist, Hem/Onc at Bristol Myers Squibb, where she oversees the operational execution of all safety-related clinical trial activities, develops materials for Safety Management Team and Safety Data Review meetings, and leads the adjudication and analysis of signal detection outputs.
Education and Expertise
Rosemary Hema Kufuor has an extensive educational background with degrees in Business Administration (MBA) from NLU, Nursing (BSN) from Lewis University, and Counseling (Master of Arts) from Trinity College. Her education supports her multifaceted role in clinical trials and drug safety.
Professional Background
Rosemary has held various roles in prominent organizations. She worked at Celgene from 2008 to 2019 in multiple capacities, including Associate Director, Safety Science, and Senior Trials Safety Manager. Before that, she was at MedImmune as Senior Product Safety Analyst from 2005 to 2008. Her career also includes roles at Abbott as Medical Specialist and Senior Medical Specialist from 2001 to 2005, and at Advocate Health Care as Charge Nurse from 1997 to 2005.
Achievements
Rosemary has played a key role in the pharmaceutical sector, including the successful approval of Fedratinib in the US and Pomalyst PVD in the EU and Japan. She provided safety input for the NDA submission for multiple myeloma treatment with pomalidomide to the FDA. Additionally, she represented Drug Safety during an FDA onsite inspection in 2012 and managed large Phase 2 & 3 trials, contributing significantly to the success of pomalidomide multiple myeloma studies.